During the past decade, Virgen Cardiovascular Research SC conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Virgen Cardiovascular Research SC" are "Obesity" (2 trials), "Dyslipidemias" (1 trials), "Heart Failure With Preserved Ejection Fraction" (1 trials), "Hyperlipoproteinemia" (1 trials) and "Lipid Metabolism Disorders" (1 trials). Many other conditions were trialed in "Virgen Cardiovascular Research SC" in a lesser frequency.

Most popular intervention types in "Virgen Cardiovascular Research SC" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Tirzepatide" (2 trials), "LY3561774" (1 trials) and "LY3819469" (1 trials). Other intervention names were less common.

The vast majority of trials in "Virgen Cardiovascular Research SC" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Virgen Cardiovascular Research SC". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Virgen Cardiovascular Research SC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Virgen Cardiovascular Research SC, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".